CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced completion of the development stage of its ePlex system, positive preliminary fourth quarter 2014 results, and the closing of a debt facility of up to $40 million led by GE Capital, Healthcare Financial Services.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
